In the news this morning, a drug company whose 32-year-old CEO announced a 5000% markup on a lifesaving drug earlier this week has had a change of heart. Originally, the price of the drug, Daraprim, was increased from $13.50 per tablet to $750 per tablet. The drug has been around for 62 years and is lifesaving for AIDS and cancer patients. The CEO promised yesterday to lower the price within two weeks. The topic will surely be a campaign issue for the 2016 election.